BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6988155)

  • 1. Newer antihypertensive agents.
    Thind GS
    Compr Ther; 1980 Mar; 6(3):36-42. PubMed ID: 6988155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the medical management of renovascular hypertension.
    Vidt DG
    Urol Clin North Am; 1984 Aug; 11(3):417-24. PubMed ID: 6087531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern concepts in the drug treatment of arterial hypertension.
    van Zwieten PA
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):412-9. PubMed ID: 6108920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the efficacy of angiotensin receptor blockers in treatment of hypertension.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S386-91. PubMed ID: 16300453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational basis for drug treatment of hypertension.
    Chalmers JP
    Aust N Z J Med; 1981; 11(Suppl 1):69-72. PubMed ID: 6114729
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in pharmacologic management of hypertension in the United States.
    Manolio TA; Cutler JA; Furberg CD; Psaty BM; Whelton PK; Applegate WB
    Arch Intern Med; 1995 Apr; 155(8):829-37. PubMed ID: 7717791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
    Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
    Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy and combined treatment with captopril.
    Radó J
    Acta Physiol Hung; 1988; 72 Suppl():23-35. PubMed ID: 3075400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rational hypertension treatment].
    Canova CR
    Schweiz Med Wochenschr; 1996 Aug; 126(33):1394-9. PubMed ID: 8830397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pindolol as an antihypertensive agent].
    Pinggera WF; Fitscha P; Stummvoll HK; Wolf A; Dorda P
    Fortschr Med; 1977 Feb; 95(5):310-14. PubMed ID: 838451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension in patients with diabetes].
    Poulsen PL; Hansen KW; Gaede PH; Rossing P
    Ugeskr Laeger; 2009 Jun; 171(24):2031-4. PubMed ID: 19523370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antihypertensive therapy with left cardiac insufficiency].
    Schröder H
    Med Monatsschr Pharm; 2005 Dec; 28(12):443-4. PubMed ID: 16389872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.